Syschem (India) Limited , a pharmaceutical manufacturer, has announced a significant expansion of its production capabilities, focusing on antibiotics including amoxicillin. The company's board of directors has approved plans for both a new factory and the expansion of an existing unit, marking a substantial investment in its manufacturing infrastructure.

New Production Unit

The board has given the green light for setting up an additional production unit at the company's existing plant in Village Bargodam, Tehsil Kalka, District Panchkula, Haryana. This new facility will be dedicated to manufacturing key antibiotic products, including:

• Cloxacillin Sodium
• Dicloxacillin Sodium
• Flucloxacillin Sodium

Expansion of Existing Amoxicillin Unit

In addition to the new unit, Syschem (India) is set to expand its recently established amoxicillin production facility. This expansion aims to significantly increase the production capacity of amoxicillin, a widely used antibiotic.

Capacity and Investment Details

The company has provided detailed information about the expansion:

The existing plant operates at a maximum production capacity of 90%, with an average utilization of 77%.

Strategic Rationale

Syschem (India) cites several strategic reasons for this expansion:

1. Improving overall operational efficiency
2. Strengthening the product portfolio
3. Meeting growing customer demand
4. Increasing overall plant capacity

Market Impact

This expansion positions Syschem (India) to capitalize on the growing demand for antibiotics in the pharmaceutical market. The introduction of new antibiotic products alongside increased amoxicillin production capacity could potentially strengthen the company's market position in the antibiotic segment.

The company expects to commence commercial production from these new and expanded facilities by the end of December 2025. This move represents a significant step in Syschem (India)'s growth strategy, potentially enhancing its competitiveness in the pharmaceutical industry.

Syschem (India) Limited , a company listed on the BSE, has recently concluded a legal battle that resulted in a favorable outcome but with a financial impact. The company, headquartered in Village Bargodam, Tehsil Kalka, District Panchkula, Haryana, received a court order disposing of a litigation case filed against it.

Case Details

The case, filed by Shri Shubham Road Carer against Syschem, was heard at the City Civil Court in Secunderabad by the Additional Chief Judge. The nature of the case fell under Order VII R1& 3R/W Section 26 of CPC.

Court Decision

In a turn of events favorable to Syschem, the plaintiff filed a memo stating that the suit was not being pursued. Consequently, the court dismissed the suit as not pressed. This decision effectively concluded the legal proceedings in Syschem's favor.

Financial Implications

Despite winning the case, Syschem faces a total financial impact of Rs 15.00 lakh. This amount is broken down as follows:

Compliance and Disclosure

In adherence to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Syschem promptly informed the BSE Limited about the case's disposal. This disclosure aligns with the SEBI circular no. SEBI/HO/CFD/CMD1/CIR/P/2019/140 dated November 21, 2019, and the SEBI Master Circular dated July 11, 2023.

The company's commitment to transparency is evident in its timely communication of this legal development to its stakeholders and the regulatory authorities. As the legal matter concludes, Syschem moves forward, having fulfilled its disclosure obligations while managing the financial implications of the case.